Wound Treatments - Venezuela
Wound treatments recorded current retail value growth of 40% in 2009, with sales reaching BsF7.3million. The area benefited from an increase in demand combined with above inflation price increases. Wound treatments remains in an early stage of development and demand is increasing rapidly as availability rises within drugstores and other modern retail chains. However, sales are currently mainly limited to middle and upper income groups as most lower income consumers cannot afford such products.
Euromonitor International's Wound Treatments in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Other Wound Treatments, Sticking Plasters.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Wound Treatments in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Other Wound Treatments, Sticking Plasters.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Wound Treatments market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Wound Treatments in Venezuela
Euromonitor International
October 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Consumer Healthcare Performs Well Despite Global Slowdown
Uncertainty Over Policies and Regulations Affecting Investment and Innovation
Strong Competition Among Firms, With Herbalife Leading Sales
Parapharmacies/drugstores Lead Distribution Sales
Positive But Moderate Forecast Period Growth Due To Increasing Regulation
High Risk of Running Business in Venezuela Limits Private Investment
Preferential Treatment for Pharmaceutical Products Fuels Growth
Firms Expand Their Corporate Social Responsibility Programmes
Increasing Public Health Problems Influencing the Industry
Firms Apply Segmentation by Gender and Age To Create Market Niches
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sector and Subsector Definitions
Summary 1 Research Sources
Konsuma De Venezuela SA
Strategic Direction
Key Facts
Summary 2 Konsuma de Venezuela SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Konsuma de Venezuela SA: Competitive Position 2009
Laboratorios Elmor SA
Strategic Direction
Key Facts
Summary 4 Laboratorios Elmor SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 5 Laboratorios Elmor SA: Competitive Position 2009
Laboratorios Genven SA
Strategic Direction
Key Facts
Summary 6 Laboratorios Genven SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Laboratorios Genven SA: Competitive Position 2009
Rep No Hagas Dieta Olalde Ca
Strategic Direction
Key Facts
Summary 8 Rep No Hagas Dieta Olalde CA: Key Facts
Company Background
Competitive Positioning
Summary 9 Rep No Hagas Dieta Olalde CA: Competitive Position 2009
Vargas Ca
Strategic Direction
Key Facts
Summary 10 Vargas CA: Key Facts
Company Background
Production
Competitive Positioning
Summary 11 Vargas CA: Competitive Position 2009
Trends
Category Data
Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 13 Wound Treatments Company Shares by Value 2005-2009
Table 14 Wound Treatments Brand Shares by Value 2006-2009
Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Euromonitor International
October 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Consumer Healthcare Performs Well Despite Global Slowdown
Uncertainty Over Policies and Regulations Affecting Investment and Innovation
Strong Competition Among Firms, With Herbalife Leading Sales
Parapharmacies/drugstores Lead Distribution Sales
Positive But Moderate Forecast Period Growth Due To Increasing Regulation
High Risk of Running Business in Venezuela Limits Private Investment
Preferential Treatment for Pharmaceutical Products Fuels Growth
Firms Expand Their Corporate Social Responsibility Programmes
Increasing Public Health Problems Influencing the Industry
Firms Apply Segmentation by Gender and Age To Create Market Niches
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sector and Subsector Definitions
Summary 1 Research Sources
Konsuma De Venezuela SA
Strategic Direction
Key Facts
Summary 2 Konsuma de Venezuela SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Konsuma de Venezuela SA: Competitive Position 2009
Laboratorios Elmor SA
Strategic Direction
Key Facts
Summary 4 Laboratorios Elmor SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 5 Laboratorios Elmor SA: Competitive Position 2009
Laboratorios Genven SA
Strategic Direction
Key Facts
Summary 6 Laboratorios Genven SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Laboratorios Genven SA: Competitive Position 2009
Rep No Hagas Dieta Olalde Ca
Strategic Direction
Key Facts
Summary 8 Rep No Hagas Dieta Olalde CA: Key Facts
Company Background
Competitive Positioning
Summary 9 Rep No Hagas Dieta Olalde CA: Competitive Position 2009
Vargas Ca
Strategic Direction
Key Facts
Summary 10 Vargas CA: Key Facts
Company Background
Production
Competitive Positioning
Summary 11 Vargas CA: Competitive Position 2009
Trends
Category Data
Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 13 Wound Treatments Company Shares by Value 2005-2009
Table 14 Wound Treatments Brand Shares by Value 2006-2009
Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
